Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Journal of the American Chemical Society
|
March 30, 1977
Biosynthesis of Cephalotaxus alkaloids. 3. Specific incorporation of phenylalanine into cephalotaxine
J M Schwab, M N Chang, R J Parry
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1989
Recent development of platelet-activating factor antagonists
T Y Shen, I Hussaini, S B Hwang, et al.
American Journal of Clinical Oncology
|
October 1, 1986
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer
J N Ingle, H J Long, A J Schutt, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|
March 1, 1987
[Studies on the chemical constituents of Piper hancei Maxim (II)]
S M Li, G Q Han, B H Arison, et al.
Biometrics
|
December 1, 1987
Designs for group sequential phase II clinical trials
M N Chang, T M Therneau, H S Wieand, et al.
Statistics in Medicine
|
May 22, 1998
Modelling cure rates using the Gompertz model with covariate information
P W Gieser, M N Chang, P V Rao, et al.
Cancer Treatment Reports
|
May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients
E T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomas
J H Edmonson, H J Long, E T Creagan, et al.
Cancer Treatment Reports
|
September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma
E T Creagan, D L Ahmann, H J Long, et al.
Cancer
|
February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses
E T Creagan, D L Ahmann, S Frytak, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Journal of the American Chemical Society
|
March 30, 1977
Biosynthesis of Cephalotaxus alkaloids. 3. Specific incorporation of phenylalanine into cephalotaxine
J M Schwab, M N Chang, R J Parry
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1989
Recent development of platelet-activating factor antagonists
T Y Shen, I Hussaini, S B Hwang, et al.
American Journal of Clinical Oncology
|
October 1, 1986
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer
J N Ingle, H J Long, A J Schutt, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|
March 1, 1987
[Studies on the chemical constituents of Piper hancei Maxim (II)]
S M Li, G Q Han, B H Arison, et al.
Biometrics
|
December 1, 1987
Designs for group sequential phase II clinical trials
M N Chang, T M Therneau, H S Wieand, et al.
Statistics in Medicine
|
May 22, 1998
Modelling cure rates using the Gompertz model with covariate information
P W Gieser, M N Chang, P V Rao, et al.
Cancer Treatment Reports
|
May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients
E T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomas
J H Edmonson, H J Long, E T Creagan, et al.
Cancer Treatment Reports
|
September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma
E T Creagan, D L Ahmann, H J Long, et al.
Cancer
|
February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses
E T Creagan, D L Ahmann, S Frytak, et al.
Page
of 5